Search by Drug Name or NDC
NDC 24275-0525-01 Gallium Ga-68 PSMA-11 5 mCi/mL Details
Gallium Ga-68 PSMA-11 5 mCi/mL
Gallium Ga-68 PSMA-11 is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by UCSF Radiopharmaceutical Facility. The primary component is GALLIUM GA-68 GOZETOTIDE.
Product Information
| NDC | 24275-0525 |
|---|---|
| Product ID | 24275-0525_09ac17d8-d7de-6ecf-e063-6394a90aff66 |
| Associated GPIs | 94356530302020 |
| GCN Sequence Number | 081735 |
| GCN Sequence Number Description | gallium Ga-68 gozetotide VIAL 18.5-185 INTRAVEN |
| HIC3 | Z5B |
| HIC3 Description | RADIOPHARMACEUTICALS ELEMENTS |
| GCN | 48934 |
| HICL Sequence Number | 047013 |
| HICL Sequence Number Description | GALLIUM GA-68 GOZETOTIDE |
| Brand/Generic | Generic |
| Proprietary Name | Gallium Ga-68 PSMA-11 |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | GALLIUM GA-68 GOZETOTIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mCi/mL |
| Substance Name | GALLIUM GA-68 GOZETOTIDE |
| Labeler Name | UCSF Radiopharmaceutical Facility |
| Pharmaceutical Class | Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA212643 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24275-0525-01 (24275052501)
| NDC Package Code | 24275-0525-1 |
|---|---|
| Billing NDC | 24275052501 |
| Package | 11 mL in 1 VIAL, MULTI-DOSE (24275-0525-1) |
| Marketing Start Date | 2020-12-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |